Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label crossover evaluation of Dysport versus Botox for upper facial rhytids
2005-005254-41Phase 2Completed
- Sponsor
- Aalst Dermatology Group
- Start
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of botulinum toxin type A in facial rhytids, sponsored by Aalst Dermatology Group. Primary endpoint: Subject evaluation of treatment. Started Dec 2005; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
facial rhytids
Beyond the preview
Go deeper on 2005-005254-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005254-41.